MedTrace Logo

Smart SCALEs With Bioimpedance Analysis for Treatment Guidance in Decompensated Heart Failure

NCT03288701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2020-03-25

No results posted yet for this study

Summary

In this trial the measurement of whole body water will be compared to the standard method of measuring the body weight as treatment guidance in patients with decompensated heart failure. The Seca mBCA 515 \[medical Body Composition Analyser\] will be used to quantify the whole body water by using bioelectrical impedance analysis.

Conditions

  • Heart Failure; With Decompensation

Interventions

DEVICE

Seca medical Body Composition Analyser 515

Comparison of reduction of whole body water and body weight in patients with decompensated heart failure under forced diuretic treatment

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Jens Eckstein, MD, PhD · University Hospital, Basel, Switzerland

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-04
Primary Completion
2019-09-27
Completion
2019-09-27

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03288701 on ClinicalTrials.gov